Ziming Li, MD
Shanghai Chest Hospital
2
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Xiaojun Zhu, PhD
China National Institute for Occupational Safety and Health (NIOSH/CDC)
Shared therapeutic areas:
Worked with same sponsors:
Kezhong Chen, MD
Peking University People's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jun Yin, MD
Shanghai Zhongshan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Rong Yin, MD
Jiangsu Cancer Institute & Hospital
Shared therapeutic areas:
Worked with same sponsors:
Yuan Cheng, MD
Peking University First Hospital
Shared therapeutic areas:
Worked with same sponsors:
Zizi Zhou, MD
Shenzhen Third People's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Yintao Li, MD
Shandong Cancer Hospital and Institute
Shared therapeutic areas:
Worked with same sponsors:
Quanfu Huang, MD
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Jiatao Zhang, MD
Guangdong Provincial People's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Fang Wu, MD
Second Xiangya Hospital of Central South University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
This is a Multicenter, Open-label, Phase I/II Study to Explore the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of GFH276 in Patients With Advanced NSCLC Harboring a RAS Mutation.
All 2 trials loaded